颊针治疗疼痛管理的疗效与安全性:系统综述与Meta分析
该系统综述与Meta分析检索8个数据库至2025年1月25日,纳入40项RCT共3009例患者。与对照干预相比,颊针提高总有效率(RR=1.19)、降低不良反应发生率(RR=0.46)、改善VAS评分(SMD=-1.51),但需更高质量大样本RCT验证。
要点
- 颊针在疼痛管理中较常规针灸和药物治疗可能具有优势。
- 颊针可降低不良反应发生率,并改善疼痛VAS评分。
- 颊针可作为常规镇痛治疗的辅助疗法,但证据质量有限。
核心结论
- 颊针在疼痛管理方面较常规针灸和药物治疗具有一定优势,包括不良反应发生率更低和镇痛效果更优。
- 颊针可能作为临床实践中常规镇痛治疗的辅助疗法。
- 上述结论仍需更高质量、大样本的临床随机对照试验进一步验证。
研究设计与样本
- 系统检索8个数据库(PubMed、Web of Science、Embase、Cochrane Library等)自建库至2025年1月25日的随机对照试验。
- 采用Cochrane偏倚风险工具评估纳入研究的方法学质量。
- 使用RevMan 5.3和Stata 15进行Meta分析。
- 共纳入40项RCT,涉及3009例患者。
主要发现
- 与对照干预相比,颊针提高总有效率[RR=1.19,95%CI(1.13,1.24),p<0.00001]。
- 与对照干预相比,颊针降低不良反应发生率[RR=0.46,95%CI(0.37,0.57),p<0.00001]。
- 与对照干预相比,颊针对VAS评分有更好效果[SMD=-1.51,95%CI(-1.98,-1.04),p<0.00001]。
- VAS用于评估疼痛强度,分值越高表示疼痛越严重。
关键数值与推荐
- 总有效率:RR=1.19,95%CI(1.13,1.24),p<0.00001。
- 不良反应发生率:RR=0.46,95%CI(0.37,0.57),p<0.00001。
- VAS评分:SMD=-1.51,95%CI(-1.98,-1.04),p<0.00001。
临床怎么用
- 颊针可作为常规镇痛治疗的辅助疗法用于疼痛管理。
- 临床决策时应结合患者具体情况,并知晓当前证据来自方法学质量有限的RCT。
局限性
- 结论仍需更高质量、大样本的临床随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study is to investigate the efficacy and safety of buccal acupuncture (BA) therapy for pain management through meta-analysis and systematic review. METHODS: A systematic search was conducted across eight databases (PubMed, Web of Science, Embase, Cochrane Library, etc) to identify randomized controlled trials (RCTs) evaluating the efficacy of BA in pain management. The search timeframe encompassed records form each database's inception through January 25, 2025. The Cochrane Risk of Bias Tool was utilized to assess the methodological quality of the included studies. Meta-analysis was performed using RevMan 5.3 and Stata 15. RESULTS: A total of 40 RCTs involving 3009 patients were included. Compared with the control intervention, BA improved the total effective rate [RR= 1.19, 95 %CI(1.13, 1.24), p < 0.00001], reduced the incidence of adverse reactions [RR= 0.46, 95 %CI(0.37,0.57), p < 0.00001] and showed a better effect on Visual Analogue Scale (VAS) [SMD= -1.51, 95 %CI(-1.98, -1.04), p < 0.00001] scores. The VAS was used to assess pain intensity, where higher values indicate greater pain severity. CONCLUSION: BA demonstrates certain advantages over conventional acupuncture and pharmacotherapy in pain management, with benefits including a lower incidence of adverse reactions and superior pain relief. It may serve as an adjunctive therapy to conventional analgesic treatments in clinical practice. However, further validation through higher-quality, large-sample clinical RCTs is required.
引用
- Guo L, Jia T, Yang Y, et al. Efficacy and safety of buccal acupuncture for pain management: A systematic review and meta-analysis. Complement Ther Med. 2025. PMID: 41177363. doi:10.1016/j.ctim.2025.103297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。